BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang L, Qiu W, Crooke S, Li Y, Abid A, Xu B, Finn MG, Lin F. Development of Autologous C5 Vaccine Nanoparticles to Reduce Intravascular Hemolysis in Vivo. ACS Chem Biol 2017;12:539-47. [PMID: 28045484 DOI: 10.1021/acschembio.6b00994] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
Number Citing Articles
1 Shukla R, Singh A, Handa M, Flora SJS, Kesharwani P. Nanotechnological approaches for targeting amyloid-β aggregation with potential for neurodegenerative disease therapy and diagnosis. Drug Discov Today 2021;26:1972-9. [PMID: 33892144 DOI: 10.1016/j.drudis.2021.04.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Luciano MP, Crooke SN, Nourian S, Dingle I, Nani RR, Kline G, Patel NL, Robinson CM, Difilippantonio S, Kalen JD, Finn MG, Schnermann MJ. A Nonaggregating Heptamethine Cyanine for Building Brighter Labeled Biomolecules. ACS Chem Biol 2019;14:934-40. [PMID: 31030512 DOI: 10.1021/acschembio.9b00122] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 11.3] [Reference Citation Analysis]
3 Lin K, Zhang L, Kong M, Yang M, Chen Y, Poptic E, Hoffner M, Xu J, Tam C, Lin F. Development of an anti-human complement C6 monoclonal antibody that inhibits the assembly of membrane attack complexes. Blood Adv 2020;4:2049-57. [PMID: 32396613 DOI: 10.1182/bloodadvances.2020001690] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
4 Remick DG, Ayala A, Chaudry IH, Coopersmith CM, Deutschman C, Hellman J, Moldawer L, Osuchowski MF. Premise for Standardized Sepsis Models. Shock 2019;51:4-9. [PMID: 29877959 DOI: 10.1097/SHK.0000000000001164] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 10.5] [Reference Citation Analysis]
5 Alam MM, Jarvis CM, Hincapie R, McKay CS, Schimer J, Sanhueza CA, Xu K, Diehl RC, Finn MG, Kiessling LL. Glycan-Modified Virus-like Particles Evoke T Helper Type 1-like Immune Responses. ACS Nano 2021;15:309-21. [PMID: 32790346 DOI: 10.1021/acsnano.0c03023] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 16.0] [Reference Citation Analysis]
6 Crooke SN, Zheng J, Ganewatta MS, Guldberg SM, Reineke TM, Finn M. Immunological Properties of Protein–Polymer Nanoparticles. ACS Appl Bio Mater 2019;2:93-103. [DOI: 10.1021/acsabm.8b00418] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Li Y, Clow F, Fraser JD, Lin F. Therapeutic potential of staphylococcal superantigen-like protein 7 for complement-mediated hemolysis. J Mol Med (Berl) 2018;96:965-74. [PMID: 30066197 DOI: 10.1007/s00109-018-1678-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
8 Velander P, Wu L, Henderson F, Zhang S, Bevan DR, Xu B. Natural product-based amyloid inhibitors. Biochem Pharmacol 2017;139:40-55. [PMID: 28390938 DOI: 10.1016/j.bcp.2017.04.004] [Cited by in Crossref: 84] [Cited by in F6Publishing: 69] [Article Influence: 16.8] [Reference Citation Analysis]
9 Ma L, Yang C, Zheng J, Chen Y, Xiao Y, Huang K. Non-polyphenolic natural inhibitors of amyloid aggregation. Eur J Med Chem 2020;192:112197. [PMID: 32172082 DOI: 10.1016/j.ejmech.2020.112197] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
10 Lee PW, Maia J, Pokorski JK. Milling solid proteins to enhance activity after melt-encapsulation. Int J Pharm 2017;533:254-65. [PMID: 28939464 DOI: 10.1016/j.ijpharm.2017.09.044] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
11 Crooke SN, Ovsyannikova IG, Kennedy RB, Poland GA. Immunoinformatic identification of B cell and T cell epitopes in the SARS-CoV-2 proteome. Sci Rep 2020;10:14179. [PMID: 32843695 DOI: 10.1038/s41598-020-70864-8] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 16.5] [Reference Citation Analysis]
12 Lee PW, Shukla S, Wallat JD, Danda C, Steinmetz NF, Maia J, Pokorski JK. Biodegradable Viral Nanoparticle/Polymer Implants Prepared via Melt-Processing. ACS Nano 2017;11:8777-89. [PMID: 28902491 DOI: 10.1021/acsnano.7b02786] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 7.0] [Reference Citation Analysis]
13 Fattizzo B, Kulasekararaj AG. Second-Generation C5 Inhibitors for Paroxysmal Nocturnal Hemoglobinuria. BioDrugs 2020;34:149-58. [PMID: 31916226 DOI: 10.1007/s40259-019-00401-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]